A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam, for Patients Suffering From Epilepsy and Coming From the Study N01175 (NCT00175903)

Trial Profile

A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam, for Patients Suffering From Epilepsy and Coming From the Study N01175 (NCT00175903)

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2015

At a glance

  • Drugs Levetiracetam (Primary) ; Carbamazepine; Valproic acid
  • Indications Epilepsy; Seizures
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms KOMET
  • Sponsors UCB
  • Most Recent Events

    • 05 Dec 2008 Results were presented at the 2008 Annual Meeting of the American Epilepsy Society.
    • 29 May 2008 Actual patient number added from ClinicalTrials.gov.
    • 26 Oct 2007 Status change from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top